Ignite Creation Date:
2024-05-19 @ 5:33 PM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06413095
Status:
COMPLETED
Last Update Posted:
2024-05-14
First Post:
2024-04-01
Brief Title:
PBI-MST-01 NCT04541108 Substudy MSD-03 Intratumoral Microdosing of Pembrolizumab Alone and With MK-0482 or MK-4830 in HNSCC or STS
Sponsor:
Presage Biosciences
Organization:
Presage Biosciences
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Head and Neck Squamous Cell Carcinoma |
| Soft Tissue Sarcoma |
Keywords:
| Name | View |
|---|---|
| HNSCC | View |
| head and neck cancer | View |
| head and neck squamous cell carcinoma | View |
| STS | View |
| soft tissue sarcoma | View |
| intratumoral microdosing | View |
| microdose injection | View |
| microdosing | View |
| in vivo oncology | View |
| tumor microenvironment | View |
| multiplexed immunohistochemistry | View |
| pharmacodynamic biomarkers | View |
| CIVO | View |
| master protocol | View |
| precision oncology | View |
| spatial biology | View |